SOP for Conducting Stability Studies for Controlled-Release Formulations

Procedure for Stability Studies of Controlled-Release Formulations

1) Purpose

The purpose of this SOP is to provide a standardized procedure for conducting stability studies on controlled-release formulations to evaluate their shelf life, drug release profile, and storage conditions under various environmental factors such as temperature, humidity, and light.

2) Scope

This SOP applies to all controlled-release formulations, including tablets, capsules, and injectable depots, that require stability testing to ensure consistent release and product quality over time. It is relevant for personnel in quality control, research and development, and regulatory affairs departments.

3) Responsibilities

The responsibilities for conducting stability studies for controlled-release formulations are as follows:

Quality Control Team: To perform the stability tests as per the protocol and document results.
R&D Team: To design the stability study protocol and provide technical support.
Regulatory Affairs Team: To ensure compliance with regulatory guidelines during stability testing.
Stability Study Coordinator: To manage
“The Assurance of Safe and Effective Medications: Cutting-edge Methods for Pharmaceutical Stability Testing Unveiled”
testing schedules, sample management, and data analysis.

4) Procedure

The detailed stepwise procedure for conducting stability studies for controlled-release formulations is outlined below:

Preparation of Stability Study Protocol:

4.1 Define the purpose, scope, and objective of the stability study for controlled-release formulations.
4.2 Identify the controlled-release formulation and critical quality attributes (CQAs) to be monitored (e.g., release

rate, potency, degradation products).

4.3 Determine the storage conditions to be tested (e.g., room temperature, refrigerated, light exposure).

4.4 Establish the time points for testing at each storage condition (e.g., 0, 3, 6, 12, 24 months).

4.5 Develop a protocol outlining procedures, equipment, and materials required for testing.

Sample Preparation and Storage:

4.6 Select representative samples of the controlled-release formulation for testing.
4.7 Prepare and package samples in their final storage configuration.
4.8 Store samples under specified conditions in stability chambers or other controlled environments.

Testing and Monitoring:

4.9 Retrieve samples at specified time points and perform the required tests (e.g., assay, release rate, degradation products).
4.10 Record all test results in a stability testing log sheet.
4.11 Evaluate the results against predefined acceptance criteria.

Data Analysis and Interpretation:

4.12 Analyze the stability data to identify any trends or deviations in the quality attributes.
4.13 Determine the impact of different storage conditions on the stability of the controlled-release formulation.
4.14 Document any significant findings or trends in the data.

Documentation and Reporting:

4.15 Compile a comprehensive stability study report including objectives, methods, results, and conclusions.
4.16 Ensure the report is reviewed and approved by relevant stakeholders.
4.17 Submit the report to regulatory bodies or internal stakeholders as required.

Review and Update:

4.18 Regularly review the stability study protocol and update it based on new data or regulatory changes.
4.19 Archive the approved protocol and report in a controlled document management system.

5) Abbreviations, if any

CQA: Critical Quality Attribute

6) Documents, if any

Controlled-Release Formulation Stability Study Protocol
Stability Testing Log Sheets
Stability Study Report Template

7) Reference, if any

ICH Q1A(R2): Stability Testing of New Drug Substances and Products

8) SOP Version

Version 1.0